REHAEPP-2022: Hemodynamic Impact of Epidural Anesthesia in Relation to Age in Pediatric Patients.

Sponsor
Hospital Universitario La Fe (Other)
Overall Status
Recruiting
CT.gov ID
NCT05543824
Collaborator
(none)
15
1
11.9
1.3

Study Details

Study Description

Brief Summary

Epidural analgesia is established as the gold standard in the management of post-surgical pain in multiple modalities, including the pediatric patient. It is a technique that is not without risks, but with multiple benefits such as less response to stress, less incidence of chronic pain after surgery, less incidence of nausea and vomiting and other adverse effects derived from opioids, faster recovery and increased patient and family satisfaction.

However, as I have mentioned, the epidural carries risks both in the technique itself (wet or intravascular puncture) and subsequently after the injection of medication that generates a sympathetic blockade with arterial hypotension and an increase in compensatory heart rate. Unlike in adult patients, in pediatric patients epidural and subarachnoid anesthesia are better tolerated hemodynamically due to less vagal and sympathetic activity and almost no systemic venodilation. This lower activity of the autonomic nervous system is due to its immaturity, which is why, with the growth of the infant, this anesthetic technique increasingly affects its hemodynamics, being similar to the adult at the age of 8-12 years.

The study hypothesis does not differ from that stated in physiology books and studies, but we seek to identify the direct correlation of age with the different hemodynamic parameters available with current technology (cardiac output, systemic vascular resistance, blood pressure ) in pediatric patients after epidural anesthesia.

The study will be carried out in pediatric patients undergoing major surgery that requires the placement of an epidural catheter and invasive blood pressure, without modifying in any way the usual practice of the responsible anesthesiologist. The patient's hemodynamic data will be collected at time 0 (prior to catheter placement), one minute, 5 and 10 minutes after the bolus of local anesthetic administered to measure the child's hemodynamic response and relate it to their age and development. .

Detailed Description

Through this work I seek to establish statistically and numerically a hypothesis affirmed in physiology books. In this way, if we find a positive correlation with age and hypotension, the responsible physician can be alerted to the need for possible vasoconstrictor requirements or more advanced monitoring in order to reduce intraoperative risks.

Study Design

Study Type:
Observational
Anticipated Enrollment :
15 participants
Observational Model:
Case-Only
Time Perspective:
Prospective
Official Title:
Hemodynamic Impact of Epidural Anesthesia in Relation to Age in Pediatric Patients.
Actual Study Start Date :
Sep 12, 2022
Anticipated Primary Completion Date :
Apr 18, 2023
Anticipated Study Completion Date :
Sep 10, 2023

Arms and Interventions

Arm Intervention/Treatment
Epidural and arterial catheter

Patients who require placement of an epidural catheter to control postoperative pain and invasive blood pressure will be identified, allowing advanced monitoring using the MostCare Up® device. After identification, the objective of the study will be explained and their consent will be requested to collect the data after the intervention, recording the hemodynamic data before and after the initial bolus of local anesthetic administered: 0.25% levobupivacaine, the dose of which is calculated with the Takasaki formula: 0.05ml x weight (kg) x number of dermatomes to anesthetize.

Drug: Levobupivacaine
Patients who require placement of an epidural catheter to control postoperative pain and invasive blood pressure will be identified, allowing advanced monitoring using the MostCare Up® device. After identification, the objective of the study will be explained and their consent will be requested to collect the data after the intervention, recording the hemodynamic data before and after the initial bolus of local anesthetic administered: 0.25% levobupivacaine, the dose of which is calculated with the Takasaki formula: 0.05ml x weight (kg) x number of dermatomes to anesthetize
Other Names:
  • epidural catheter
  • invasive arterial catheter
  • Outcome Measures

    Primary Outcome Measures

    1. Hemodynamic repercussion [time zero until 10 minutes]

      Drop in blood pressure after epidural levobupivacaine bolus

    2. Age related repercussion [0 years until 12 years]

      Relate the blood pressure drop to the age of the patient

    Secondary Outcome Measures

    1. Epidural level [time zero until 10 minutes]

      Asses if the epidural level (lumbar or thoracic) influence the different results

    2. Gender [time zero until 10 minutes]

      Asses if the gender of the patient influence the different results

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    0 Years to 12 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • Patients under 12 years of age undergoing major surgery with epidural catheter placement and invasive blood pressure.
    Exclusion Criteria:
    • Allergy to local anesthetics (LA).

    • Congenital diseases which affect the central nervous system.

    • Inability to place an invasive arterial catheter.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Daniel Perez Ajami Valencia Spain 46026

    Sponsors and Collaborators

    • Hospital Universitario La Fe

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    Responsible Party:
    Daniel Pérez, M.D., Hospital Universitario La Fe
    ClinicalTrials.gov Identifier:
    NCT05543824
    Other Study ID Numbers:
    • REHAEPP-2022
    First Posted:
    Sep 16, 2022
    Last Update Posted:
    Sep 16, 2022
    Last Verified:
    Sep 1, 2022
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    Yes
    Studies a U.S. FDA-regulated Device Product:
    No
    Product Manufactured in and Exported from the U.S.:
    No
    Keywords provided by Daniel Pérez, M.D., Hospital Universitario La Fe
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Sep 16, 2022